Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-08-17FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of dapagliflozin and metformin hydrochloride, developed by Prasco Lab…
-
FDA approval · 2016-08-17FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc. The…
-
FDA approval · 2016-08-05FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog KwikPen (insulin lispro) submitted by Eli Lilly and Company.
-
FDA approval · 2016-08-01FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic metformin hydrochloride product from Sun Pharmaceutical Industries as an original application (ANDA), enabling generi…
-
FDA approval · 2016-07-11FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' metformin hydrochloride as an Original Application (ANDA) product. The approval makes a generic me…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-07-08FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY (empagliflozin and metformin hydrochloride) filed by Boehringer Ingelheim Pharmaceutica…
-
FDA approval · 2016-07-08FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Tresiba (insulin degludec) from Novo Nordisk.
-
FDA approval · 2016-07-06FDA Approved: NATEGLINIDE — Original Application (Zydus Lifesciences Limited)
FDA approved Zydus Lifesciences Limited's original application for nateglinide, a meglitinide insulin secretagogue, for the treatment of typ…
-
FDA approval · 2016-06-17FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for BASAGLAR KWIKPEN (insulin glargine) by Eli Lilly and Company.
-
FDA approval · 2016-06-14FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the dapagliflozin and metformin hydrochloride combination product by Prasco Laboratories.
-
FDA approval · 2016-06-09FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Losartan Potassium (generic) from Lupin Pharmaceuticals, Inc.
-
FDA approval · 2016-06-01FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for BASAGLAR KWIKPEN (insulin glargine) filed by Eli Lilly and Company.
-
FDA approval · 2016-05-27FDA Approved: JENTADUETO XR — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved JENTADUETO XR (linagliptin and metformin hydrochloride extended-release) under an original application for adults with type…
-
FDA approval · 2016-05-27FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for alogliptin from Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2016-05-20FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKANA (canagliflozin) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2016-05-20FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc. The…
-
FDA approval · 2016-05-12FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Precision Dose, Inc.)
The FDA approved a supplemental application for metformin hydrochloride from Precision Dose, Inc., under an existing abbreviated new drug ap…
-
FDA approval · 2016-05-10FDA Approved: GLYBURIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for glyburide from Zydus Lifesciences Limited.
-
FDA approval · 2016-05-06FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Synjardy (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharm…
-
FDA approval · 2016-04-29FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin HCl) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2016-04-29FDA Approved: METFORMIN HYDROCHLORIDE EXTENDED RELEASE — Original Application (TIME CAP LABORATORIES, INC)
The FDA approved Time Cap Laboratories, Inc.'s metformin hydrochloride extended-release tablets under an original ANDA.
-
FDA approval · 2016-04-26FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for the generic drug Glipizide from Apotex Corp.
-
FDA approval · 2016-04-22FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for liraglutide filed by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2016-04-14FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc., gr…
-
FDA approval · 2016-04-07FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from Mannkind Corporation.